Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program
{{output}}
This article describes the Swiss limited access program for psychedelic/3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy. The Swiss Federal Office of Public Health can issue authorizations for the limited medical use of otherwise prohibited substances... ...
